Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
P3 Health Partners ( (PIII) ) has shared an update.
On November 21, 2025, P3 Health Partners Inc. received a notification from Nasdaq indicating non-compliance with the requirement to maintain a minimum of $2.5 million in stockholders’ equity. The company has 45 days to submit a compliance plan, and if accepted, could receive an extension to meet the requirements. The company is actively working to address this issue and remains committed to its long-term growth and profitability goals.
The most recent analyst rating on (PIII) stock is a Sell with a $5.50 price target. To see the full list of analyst forecasts on P3 Health Partners stock, see the PIII Stock Forecast page.
Spark’s Take on PIII Stock
According to Spark, TipRanks’ AI Analyst, PIII is a Underperform.
P3 Health Partners faces significant financial challenges, with high leverage and negative profitability metrics. Technical indicators suggest bearish momentum, and the valuation is unattractive due to ongoing losses. While the earnings call provided some positive insights, the financial risks remain predominant.
To see Spark’s full report on PIII stock, click here.
More about P3 Health Partners
Average Trading Volume: 6,758
Technical Sentiment Signal: Sell
Current Market Cap: $40.35M
Find detailed analytics on PIII stock on TipRanks’ Stock Analysis page.